Lisa Wynja
About Lisa Wynja
Lisa Wynja serves as the Vice President of Customer Engagement at Instil Bio, where she leverages her extensive experience in the biopharmaceutical industry to drive collaboration and influence. With a strong background in CAR-T and TIL cellular therapies, she has held various leadership roles at notable companies including Celgene and Kite Pharma.
Current Role at Instil Bio
Lisa Wynja serves as the Vice President of Customer Engagement at Instil Bio, a position she has held since 2021. In this role, she focuses on enhancing customer relationships and driving engagement strategies that align with the company's objectives. Her work involves collaborating with C-Level executives to unify goals and deliver optimal results for stakeholders. With a strong emphasis on operational excellence, she leverages her extensive experience in the biopharmaceutical sector to lead high-value initiatives.
Previous Experience at Celgene
Wynja has an extensive history with Celgene, where she held multiple roles over several years. She worked as a Senior Hematology Oncology Consultant from 2003 to 2010, followed by positions as District Sales Manager, Regional Field Sales Training Manager, Director of Professional Alliances, and Senior Manager of Professional Alliances. Her tenure at Celgene provided her with a comprehensive understanding of the oncology landscape and honed her skills in customer engagement and professional alliances.
Experience at Kite Pharma
At Kite Pharma, Wynja held significant roles that contributed to her expertise in customer engagement and strategic alliances. She served as Senior Director of Customer Engagement from 2016 to 2019 and later as Executive Director of Customer Engagement & Strategic Alliances from 2019 to 2020. Her work at Kite focused on enhancing customer relationships and developing strategic partnerships within the biopharmaceutical industry.
Expertise in Cellular Therapies
Wynja possesses specialized knowledge in CAR-T and TIL cellular therapies. Her expertise encompasses operational excellence and strategic planning, which are critical in the rapidly evolving field of cellular therapies. This background supports her ability to lead initiatives that advance patient care and engagement in innovative treatment options.
Educational Background
Lisa Wynja studied at Dordt University, where she earned a Bachelor of Arts in Exercise Physiology. She also studied Kinesiology and Exercise Science at Dordt College, achieving another Bachelor of Arts degree. Her educational background provides a strong foundation for her career in the healthcare and biopharmaceutical sectors, particularly in understanding patient needs and advocacy.